Gene therapy shows promise for haemophilia

A new type of gene therapy boosted levels of factor VIII clotting factor in a small number of people with haemophilia, allowing two severely ill patients to go for 10 months without spontaneous bleeding, a new study says.

These results are far from the proof needed to bring the treatment to market. In particular it is not clear if the effect lasts long …